Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Sunshine Pharmaceutical is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates based in China. The company primarily serves the cardiovascular, central nervous system, and anti-infective therapeutic areas. With a strong emphasis on quality and regulatory compliance, it operates multiple GMP-certified production lines to supply global markets. Their business model encompasses both the production of high-volume generic APIs and providing CDMO services for custom synthesis. Key products in their portfolio include amlodipine, gabapentin, and various specialty chemical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 常州市阳光药业.